From: Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodies
MAb | Isotype | Peptide ELISA | rOMP31 Western-Blot | NMP Western-Blot | NMP ELISA | SSP ELISA | TC IFS | B. m ICS | Epitope (aa)/peptide |
---|---|---|---|---|---|---|---|---|---|
1H2 | IgG1 (K) | 12 | ++ | − | <1 | 1 | + | − | L (33–48/42–57)/P05/06 |
2D2 | IgM (K) | 7 | ++ | ++ | 4.5 | 4.8 | + | ++ | L (33–48/42–57)/P05/06 |
2G9 | IgG1 (K) | 3 | ++ | ++ | <1 | 2.2 | + | + | L (33–48/42–57)/P05/06 |
7A3 | IgG1 (K) | 1.2 | ++ | ++ | 7 | 17 | + | + | L (33–48/42–57)/P05/06 |
5B1 | IgG2a (K) | 3.8 | + | − | 1.2 | 2 | + | ++ | L (87–102)/P11 |
2C1 | IgG2a (K) | 2.7 | ++ | ++ | 2.4 | 5.5 | ++ | ++ | L (159–174/168–183)/P19/20 |
2E7 | IgG2a (K) | 1.8 | ++ | ++ | 1.5 | 3.5 | ++ | ± | L (159–174/168–183)/P19/20 |
4E9 | IgG2a (K) | 3.7 | + | ++ | 2 | 5 | ++ | ++ | L (159–174/168–183)/P19/20 |
4H10 | IgG2a (K) | 1.9 | ++ | ++ | 2.2 | 4.2 | ++ | − | L (159–174/168–183)/P19/20 |
8F11 | IgG2a (K) | 2.2 | ++ | ++ | 2.5 | 5.5 | ++ | + | L (159–174/168–183)/P19/20 |
2A8 | IgG1 (K) | 7.8 | ++ | + | <1 | 1.5 | (+) | + | L (177–192)/P21 |
6D8 | IgG1 (K) | 4.7 | ++ | − | <1 | <1 | + | ± | L (177–192)/P21 |
5B3 | IgG2a (K) | 2.8 | ++ | + | <1 | 16 | + | ++ | L (204–219)/P24 |
2B6 | IgM (K) | <1 | ++ | − | 8 | 11 | − | + | SC(20–240) |
4H6 | IgM (K) | <1 | ++ | − | <1 | 1.2 | − | ± | SC(20–240) |
5B11 | IgM (K) | <1 | ++ | − | 5.8 | 9.2 | − | ± | SC(20–240) |
5H3 | IgG2a (K) | <1 | ++ | ++ | 11 | 18 | + | ++ | SC(20–240) |
6E10 | IgG2a (K) | <1 | + | + | 1 | 2 | ++ | − | SC(20–240) |
6F9 | IgG2a (K) | <1 | + | ++ | <1 | 1.5 | ++ | ± | SC(20–240) |
11C4 | IgG2a (K) | <1 | ++ | ++ | 1.2 | 2.6 | ++ | ± | SC(20–240) |
2H5 | IgM (K) | <1 | − | − | 4.1 | 7 | − | − | C (20–240) |
5F11 | IgM (K) | <1 | − | − | 8.2 | 12 | − | + | C (20–240) |